Trial Profile
Pharmacogenomics of Thiazolidinediones
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2024
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- Acronyms PPAR
- 25 Sep 2018 Status changed from recruiting to completed.
- 11 Sep 2017 Planned End Date changed from 1 May 2016 to 1 May 2018.
- 11 Sep 2017 Planned primary completion date changed from 1 May 2016 to 1 May 2018.